CPA3 and asthma: These findings suggest that CPA3/Cpa3 and mMCP-5 are dispensable for the development of several key features of allergic asthma, both in a milder asthma protocol, using OVA, and in a stronger and more physiologically relevant asthma protocol, using HDM as the allergen.